Marion Tardieu1, Lakhdar Khellaf2, Maida Cardoso3, Olivia Sgarbura4, Pierre-Emmanuel Colombo4, Christophe Goze-Bac3, and Stephanie Nougaret1
1Montpellier Cancer Research Institute (IRCM), INSERM U1194, University of Montpellier, Montpellier, France, 2Department of pathology, Montpellier Cancer Institute (ICM), Montpellier, France, 3BNIF facility, L2C, UMR 5221, CNRS, University of Montpellier, Montpellier, France, 4Department of Surgery, Montpellier Cancer Institute (ICM), Montpellier, France
Synopsis
The
objective was to probe the associations of high-field MR-images and their derived
texture maps (TM) with histopathology in ovarian cancer (OC). Four ovarian
tumors were imaged ex-vivo using a 9.4T-MR scanner. Automated MR-derived stroma-tumor
segmentation maps were constructed using machine learning and validated against
histology. Through TM, we found that areas of tumor cells appeared uniform on
MR-images, while areas of stroma appeared heterogeneous. Using the automated model, MRI predicted
stromal proportion with an accuracy from 61.4% to 71.9%. In this
hypothesis-generating study, we showed that it is feasible to resolve
histologic structures in OC using ex-vivo MR radiomics.
Purpose
High-grade
serous ovarian cancer (HGSOC) is the most prevalent histological subtype of
ovarian cancer1. Response to neoadjuvant treatment at histopathology
manifests as an increase of stromal tissue and decreased of tumor cells but
those changes cannot be assessed on clinical imaging2. Radiomic
analysis extracts large amount of quantitative data and has the potential to
uncover salient features that are imperceptible to human observers, yet
possibly reflective of microscopic changes in tumor in response to treatment3.
It is now well established that the stroma contributes to ovarian tumorigenesis
and progression4. Being able to assess the stroma-tumor ratio in a
non-invasive way with radiomics may open a new pathway in assessing tumor
response in HGSOC. The aim of this proof-of-concept study was to evaluate the
correlation between tumor-stroma maps derived from high-field MR images and
whole histopathology slide images (WHSI) of histopathologic specimens and to
develop an automated visual map of stromal proportion in HGSOC peritoneal
implants using quantitative analysis of MR images.Methods
Four peritoneal implants were excised from
patient with HGSOC and fixed in formalin solution. Fixed specimens were
immersed in saline with 1% Gd-BOPTA during 1h, then in fluorinert solution to
be imaged with a 9.4T-MR scanner. Images were acquired using a T1w
fat-suppressed gradient-echo sequence with a voxel resolution of $$$90\times 90 \times 180$$$
µm3 with sequence parameters
presented in Table 1.
Images were preprocessed following IBSI guidelines5. Texture feature
maps were extracted on a per-pixel basis with an in-house software implemented
in Matlab: gray level co-ocurence matrix was computed for each pixel using the
3 neighboring pixels of each direction, allowing the extraction of 13 Haralick
feature maps. After MR experiments, excised implants were cut into 4µm sections
according to MRI slice plane for histology analysis. Stroma and tumor regions
were segmented on histology and stromal proportion was assigned to each pixel
by measuring this proportion in a circular neighborhood with radius of 3
pixels. Histology images were aligned on MR images using a non-linear
registration with 3D-Slicer, allowing a pixel-wise comparison. Pixels were labelled
as stroma-rich (stromal proportion>50%) and stroma-poor (stromal
proportion<50%), leading to a common classification table with 58946 pixels
associated with 14 inputs (13 features and their label). 50% of the pixels were
randomly selected to train the machine learning model with balanced number of stroma-rich
and –poor pixels; the 50% remaining pixels was used to test the algorithm. Classification
model was completed using SVM classifier and 20-fold cross-validation, with
classification learner toolbox of Matlab 2020a. Finally, this trained algorithm
was applied to the 4 tumors separately to generate predicted segmentation maps
and were compared to the stroma-rich and -poor segmentations, extracted from
the histopathologic images.Results
Figure 1 illustrates energy, entropy and
homogeneity maps from a representative peritoneal carcinomatosis implant, with
corresponding tumor-stroma segmentation and stromal proportion maps. Stromal
proportion map was divided into increments of 10 percentage points and mean
texture values were calculated for these 10 regions. Correlation plots between
mean texture feature values and stromal proportion were constructed (Figure 2.a)
and Pearson’s correlation coefficients with corresponding p-values were then
determined (Figure 2.b). Estimated
segmentation maps were performed using the training SVM model and are presented
in Figure 3 with their corresponding stroma-rich and –poor histological
segmentations, allowing confusion matrix calculation (Table 2). An accuracy for
predicting stromal proportion from MRM images ranged from 61.4 to 71.9% on the
holdout test data.Discussion
In our study, we correlated radiomics features
with tumour/stromal proportion pixel-by-pixel. Here, entropy, correlation,
difference entropy and sum entropy radiomics features were positively
associated with stromal proportion while MR signal intensity, energy,
homogeneity, auto correlation, difference variance and sum radiomics features
were positively associated with tumor proportion. Energy feature is high when
MR image grayscale is uniform; in contrast, entropy value is high when the MR
image is disorderly. In this work, we found that areas of tumor cells appeared
uniform on MR images, while areas of stroma appeared heterogeneous. Those
radiomics features associated with stroma heterogeneity may be explained by
stroma neoangiogenesis known to be disorderly and the consistence of the stroma
itself.
In this work, we built a model allowing to
compute a visualize map of estimated stromal and tumor regions from MR images.
The 4 generated predicted segmentation maps were compared to the actual
segmentation maps measured from histology and found a good accuracy (61.4% to
71.9%). Relative low accuracy values can be explained by the presence of
histological structures not taken into account in the model training, such as
glandular lumens resulting in signal loss. These values can also be explained
by the difference of slice thickness between MR and histological images, with a
factor of 45%.
Finally, predicted segmentation maps allowed us
to assess the stroma-tumor ratio by ex-vivo imaging. Multiple studies have
demonstrated the importance of stroma in ovarian tumorigenesis, progression and
in reduced overall survival6. Future on-going work will try to translate
this ex-vivo findings to in-vivo real time evaluation from 1.5 or 3T scanners
used in clinical routine.Conclusion
In this proof of concept study, high-field MRI with radiomics
analysis allowed us to associate texture features to tumor and stromal
proportionAcknowledgements
This
research was funded by foundation de l’Avenir grant and SIRIC Montpellier
Cancer Grant INCa-DGOS-Inserm_12553.References
1. Torre L A, Trabert B, DeSantis C E, et al. Ovarian cancer statistics, 2018. CA:
a cancer journal for clinicians. 2018 ; 68(4),: 284-296.
2. Jacob F, Marchetti R L, Kind A B, et
al. High‐grade serous peritoneal cancer follows a high stromal response
signature and shows worse outcome than ovarian cancer. Molecular Oncology. 2021;
15(1), 91-103.
3. Lambin
P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using
advanced feature analysis. European journal of cancer. 2012 ; 48(4), 441-446.
4. Greenaway J, Moorehead R, Shaw P,
Petrik J. Epithelial–stromal interaction increases cell proliferation, survival
and tumorigenicity in a mouse model of human epithelial ovarian cancer.
Gynecologic oncology. 2008; 108(2), 385-394.
5. Zwanenburg A, Leger S, Vallières M,
Löck S. Initiative for the IBS. Image biomarker standardisation initiative.
2016.
6. Labiche
A, Heutte N, Herlin P, et al. Stromal
compartment as a survival prognostic factor in advanced ovarian carcinoma.
International Journal of Gynecologic Cancer. 2010 ; 20(1).